Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...
As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
Diversity in clinical trials matters for drug safety and efficacy—and for future medical advancements. Clinical trial ...
What’s the Difference Between Nontherapeutic and Therapeutic? Benefits of Nontherapeutic Clinical Trials Examples of Nontherapeutic Clinical Trials How to Find a Nontherapeutic Clinical Trial When you ...
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...
However, traditional clinical trial designs are often ill-suited for rare disease research with common challenges including ...
Identifying Health Information Technology Needs of Oncologists to Facilitate the Adoption of Genomic Medicine: Recommendations From the 2016 American Society of Clinical Oncology Omics and Precision ...
Clinical trial agreements (CTAs) form the foundation of any clinical research initiative, establishing the legal and operational framework essential for a study's success. Crafting, reviewing, and ...
When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...
Photo-Illustration by Chloe Dowling for TIME (Source Images: Maki Nakamura—Getty Images, Tara Moore—Getty Images, We Are/Getty Images, Leland Bobbe—Getty Images, Willie B. Thomas—Getty Images, Morsa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results